Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Spedding

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Stroke|January 10, 2002
Reasons why stroke trials underestimate the neuroprotective effects of drugsMichael Spedding
Dialogues in Clinical Neuroscience|November 23, 2006
New directions for drug discoveryMichael Spedding
Cells|November 13, 2025
Does Amyotrophic Lateral Sclerosis (ALS) Have Metabolic Causes from Human Evolution?Michael Spedding
Neuropharmacology|August 17, 2010
Resolution of controversies in drug/receptor interactions by protein structure. Limitations and pharmacological solutionsMichael Spedding
Seminars in Fetal & Neonatal Medicine|March 14, 2007
Clinical trials in neonates: ethical issuesPeter Allmark, Michael Spedding
Medecine Sciences : M/S|January 11, 2005
[Synaptic plasticity and neuropathology: new approaches in drug discovery]Michael Spedding, Pierre Lestage
Novartis Foundation Symposium|May 24, 2008
Neurotrophins and cytokines in neuronal plasticityMichael Spedding, Pierre Gressens
Nature|July 20, 2012
Olympics: Run for your lifeTimothy Noakes, Michael Spedding
Cardiovascular Research|December 22, 2018
Scientists on the Spot: the Guide to Immunopharmacology as a new resource for the cardiovascular communityPasquale Maffia, Alberto Mantovani, Michael Spedding
Current Opinion in Pharmacology|January 29, 2003
Brain plasticity and pathology in psychiatric disease: sites of action for potential therapyMichael Spedding, Isabelle Neau, Laszlo Harsing
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Stroke|January 10, 2002
Reasons why stroke trials underestimate the neuroprotective effects of drugsMichael Spedding
Dialogues in Clinical Neuroscience|November 23, 2006
New directions for drug discoveryMichael Spedding
Cells|November 13, 2025
Does Amyotrophic Lateral Sclerosis (ALS) Have Metabolic Causes from Human Evolution?Michael Spedding
Neuropharmacology|August 17, 2010
Resolution of controversies in drug/receptor interactions by protein structure. Limitations and pharmacological solutionsMichael Spedding
Seminars in Fetal & Neonatal Medicine|March 14, 2007
Clinical trials in neonates: ethical issuesPeter Allmark, Michael Spedding
Medecine Sciences : M/S|January 11, 2005
[Synaptic plasticity and neuropathology: new approaches in drug discovery]Michael Spedding, Pierre Lestage
Novartis Foundation Symposium|May 24, 2008
Neurotrophins and cytokines in neuronal plasticityMichael Spedding, Pierre Gressens
Nature|July 20, 2012
Olympics: Run for your lifeTimothy Noakes, Michael Spedding
Cardiovascular Research|December 22, 2018
Scientists on the Spot: the Guide to Immunopharmacology as a new resource for the cardiovascular communityPasquale Maffia, Alberto Mantovani, Michael Spedding
Current Opinion in Pharmacology|January 29, 2003
Brain plasticity and pathology in psychiatric disease: sites of action for potential therapyMichael Spedding, Isabelle Neau, Laszlo Harsing
Pageof 13